TMCnet News
Nymox Pharmaceutical Down 18.1% Since SmarTrend Downtrend Call (NYMX)Jul 09, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for Nymox Pharmaceutical (NASDAQ:NYMX) on February 4th, 2013 at $6.36. In approximately 5 months, Nymox Pharmaceutical has returned 18.08% as of today's recent price of $5.21. Over the past year, Nymox Pharmaceutical has traded in a range of $4.20 to $8.53 and is now at $5.21, 24% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has remained constant. Nymox Pharmaceutical Corporation is a biopharmaceutical company. The Company is engaged in therapeutics in development for enlarged prostate (BPH), E. coli, Alzheimer's disease and other indications and diagnostics for tobacco exposure, Alzheimer's disease and other conditions. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Nymox Pharmaceutical. Log in and add Nymox Pharmaceutical (NYMX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |